Navigation Links
Sorrento Therapeutics Presents Preclinical Data of its Fully Human Antibody Programs Targeting Anti-PD-L1 and Anti-PD-1 at the 8th Annual Next Generation Protein Therapeutics Summit
Date:6/24/2013

SAN DIEGO, June 24, 2013 /PRNewswire/ -- Sorrento Therapeutics, Inc. (OTCQB: SRNE; Sorrento) announced today that preclinical data of its therapeutic fully human anti-PD-L1 and anti-PD-1 monoclonal antibodies (mAbs) will be presented at the IBC 8th Annual Next Generation Protein Therapeutics Summit, June 26 - 28 in San Diego.

In recent clinical studies,[1] immunomodulatory anti-PD-1 and anti-PD-L1 antibodies have shown great promise for the treatment of solid tumors. By blocking immunosuppressive signals on cancer cells directed against infiltrating T cells, the patients' anti-tumor immune response might be rejuvenated.

"We believe these preclinical data are the first demonstration of potent immunomodulatory anti-PD-L1 and anti-PD-1 antibodies obtained from a fully human antibody library rather than mouse-based technologies," said Henry Ji, Ph.D., Sorrento's President and CEO. "Overall, these data illustrate the potential of Sorrento's G-MAB® library technology for discovery and development of fully human therapeutic antibodies against clinically valuable drug targets,"

The poster presentation titled "Human anti-PD-L1 and anti-PD-1 mAbs Identified from an Antibody Library Exhibit Potent Immune Cell Activation" is authored by J. Dixon Gray, Heyue Zhou, Edwige Gros, Kimberly Johnson, Gunnar F. Kaufmann, and Randy Gastwirt.

About Sorrento Therapeutics, Inc.

Sorrento Therapeutics, Inc. is a publicly-traded, development-stage biopharmaceutical company engaged in the discovery, acquisition, development and commercialization of proprietary drug therapeutics for addressing significant unmet medical needs in the Unites States, Europe an
'/>"/>

SOURCE Sorrento Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Frost & Sullivan Presents bitop AG with the 2013 New Product Innovation Award in the Extremolytes Therapeutics Market
2. Injectable Drug Delivery Market by Formulations, Devices & Therapeutics - Global Forecasts to 2017
3. North America Injectable Drug Delivery Market - by Formulations, Devices & Therapeutics- Forecasts to 2017
4. Case Western Reserve University, in Collaboration with NDI Medical, SPR Therapeutics and Valtronic Technologies, Receives $3 Million from Ohio Third Frontier Commission
5. Mast Therapeutics Prices Public Offering Of Units
6. Closed Drug Transfer Systems: Oncology Therapeutics Market Dynamics and Closed Drug Transfer Design Factors - Market Forecasts to 2017
7. PTC Therapeutics Appoints Shane Kovacs as Chief Financial Officer
8. Industry Leader John Reynders Joins Moderna Therapeutics as Chief Information Officer
9. Flexion Therapeutics Names Frederick Driscoll Chief Financial Officer
10. Cell Therapeutics to Present at Upcoming Investor Conferences
11. Orexigen Therapeutics to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... CA (PRWEB) October 30, 2014 ... today that they have manually curated public data source ... non profit customers. the data is now available ... curates and unifies public and internal data sources for ... and knowledge out of the data that becomes more ...
(Date:10/30/2014)... Grace Century portfolio project, Provia Laboratories , ... the Board, to the National Stem Cell Ethics Committee ... by the Ministry of Health on behalf of the Government ... More than a year after Bahamian Parliament passed the ... Christie said the government has completed the accompanying regulations and ...
(Date:10/30/2014)... that devastated a wide swath of Colorado last year ... and other infrastructure had been upgraded or modernized, according ... Denver. , "People need to understand the importance and ... of structural engineering at the CU Denver College of ... "There is an assumption that a bridge will stand ...
(Date:10/27/2014)... YORK , Oct. 27, 2014 Kalorama ... the recent Ebola concern in the United ... the virus.  The healthcare market researcher said the FDA,s Emergency ... in vitro diagnostic tests for the detection of the ... has proved useful.  Kalorama routinely assess the IVD industry ...
Breaking Biology Technology:Rancho BioSciences Manually Curated TCGA Data Sets Available 2Grace Century’s Stem Cell Biobank Project Announces Chairman’s Appointment to National Stem Cell Ethics Committee of The Bahamas 2Grace Century’s Stem Cell Biobank Project Announces Chairman’s Appointment to National Stem Cell Ethics Committee of The Bahamas 3CU Denver study says upgrading infrastructure could reduce flood damage 2Kalorama: PCR The Go-to Test in Ebola Fight 2Kalorama: PCR The Go-to Test in Ebola Fight 3
... Bill Gates , Co-Chair and Trustee of the Bill & Melinda ... mobile technologies to improve health outcomes in the developing world at ... The summit, organized by the Foundation for the National Institutes of ... the mHealth Alliance, will be held November 8-10 in ...
... ROCKVILLE, Md. , Aug. 2 Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: ... and commercialization of products for central nervous system disorders, today announced it will ... 2010 , before the market opens. A full text copy of the release ... , , ...
... 2 Tengion Inc. (Nasdaq: TNGN ) ... the position of Chief Financial Officer.  Mr. Davis comes to Tengion after ... to develop improved protein therapeutics. At its peak, Neose employed 200 individuals, ... , , ...
Cached Biology Technology:Bill Gates Named Keynote Speaker at the 2010 mHealth Summit 2Bill Gates Named Keynote Speaker at the 2010 mHealth Summit 3Bill Gates Named Keynote Speaker at the 2010 mHealth Summit 4Vanda Pharmaceuticals to Announce Second Quarter 2010 Financial Results on August 5, 2010 2Tengion Appoints A. Brian Davis Chief Financial Officer 2
(Date:10/29/2014)... who lose their hair as a consequence of chemotherapy ... improve the scalp cooling technology that prevents hair loss. ... being pioneered by global scalp cooling manufacturing company, Paxman ... biology department of the University of Huddersfield. , The ... who has a background in the pharmacology of cancer ...
(Date:10/29/2014)... their food, but they also need protection from its harmful ... of molecules in plants that shields them from sun damage. ... American Chemical Society , one team reports on the mechanics ... and colleagues at Purdue University note that the harsh ultraviolet ... to plant DNA and, as a result, hinder plant growth. ...
(Date:10/29/2014)... German . ... Peter Schlögelhofer at the Max F. Perutz Laboratories (MFPL) ... of Vienna dived into the process of meiosis in ... an inversion of the standard meiotic phases. The researchers ... Nature Communications . , Meiosis is the two-step series ...
Breaking Biology News(10 mins):New technology on the way to aid cancer suffers who lose their hair after chemotherapy 2Meiotic cell division 'the other way round' 2
... Aluminum salts, or alum, have been injected into billions of ... one knows, however, how they boost the immune response. In ... the National Academy of Sciences researchers at National Jewish ... that host DNA coats the alum adjuvant and induces two ...
... N.C. -- The cost of complying with tougher EPA air-quality ... toward natural gas for electricity generation, according to a new ... particulate matter, nitrogen oxide and mercury may make nearly two-thirds ... as plants powered by natural gas, the study finds. ...
... Engineering Professor Tim Bender and Post-Doctoral Fellow Benoit ... polymer synthesis could have implications for the manufacture ... and even medical implants, the researchers say. ... subphthalocyanine polymers by facile coupling to poly (acrylic ...
Cached Biology News:Vaccine adjuvant uses host DNA to boost pathogen recognition 2Vaccine adjuvant uses host DNA to boost pathogen recognition 3New emissions standards would fuel shift from coal to natural gas 2Accidental discovery may lead to improved polymers 2
... agarose is used for second-dimension SDS-PAGE ... in place in PROTEAN Plus cells. ... to allow monitoring of electrophoresis runs. ... agarose in 1x Tris, glycine, SDS, ...
... HV high-voltage power supply, with temperature probe, 100-120 ... 5,000 V, 500 mA, and 400 W. The ... between 0 and 90 degrees C during electrophoresis. ... Power cord and instructions are provided. Dimensions are ...
The stirbar is used in the buffer tank of the Trans-Blot Plus cell to maintain uniform conductivity and temperature during electrophoretic transfer. Dimensions are 3.5 x 0.5 in....
... cooling coil, Trans-Blot cell, provides ... high-intensity, and extended electrophoretic transfer ... Trans-Blot cell. Use of the ... to an external water recirculator, ...
Biology Products: